Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome

This study has been terminated.
(Neurogen acquired by Ligand Pharmaceuticals - no further support for the study. No safety concerns identified.)
Sponsor:
Information provided by:
Neurogen Corporation
ClinicalTrials.gov Identifier:
NCT00834327
First received: January 30, 2009
Last updated: October 12, 2009
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2009
  Estimated Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)